1,636,364 Shares ImmuCell Corporation Common Stock, par value $0.10 per share UNDERWRITING AGREEMENTUnderwriting Agreement • March 29th, 2019 • Immucell Corp /De/ • In vitro & in vivo diagnostic substances • New York
ImmuCell Corporation, a Delaware corporation (the “Company”), proposes to sell to Craig-Hallum Capital Group LLC (“you” or the “Underwriter”) an aggregate of 1,636,364 shares (the “Shares”) of Common Stock, par value $0.10 per share (the “Common Stock”), of the Company. The Shares consist of authorized but unissued shares of Common Stock to be issued and sold by the Company to the Underwriter.
